Hua Medicine's market cap is currently $4.70B. The company's EPS TTM is HK$1.301; its P/E ratio is 4.13; Hua Medicine is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
